Friday, March 20, 2026 | 02:23 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Page 405 - Markets News

Ireda share price slips 6% as Q1 profit plunges 36% YoY; details here

Ireda shares declined today following a disappointing financial performance in the June quarter (Q1FY26).

Ireda share price slips 6% as Q1 profit plunges 36% YoY; details here
Updated On : 11 Jul 2025 | 11:34 AM IST

Apollo Tyres shares down 3% as stock turns ex-dividend; Details here

Apollo Tyres share price slip 3 per cent logging an intraday low at ₹457.5 per share on its ex-dividend date

Apollo Tyres shares down 3% as stock turns ex-dividend; Details here
Updated On : 11 Jul 2025 | 11:29 AM IST

Asston Pharmaceuticals IPO closes today; subscription rises 26x, GMP at 24%

Asston Pharmaceuticals Day 2 subscription status: The SME offering has received bids for 38.04 million shares, against 1.6 million shares on offer

Asston Pharmaceuticals IPO closes today; subscription rises 26x, GMP at 24%
Updated On : 11 Jul 2025 | 11:19 AM IST

Dreamfolks Services hits new low, tanks 33% thus far in July; here's why

Certain programs of the clients, Axis Bank and ICICI Bank have been closed w.e.f. July 01, 2025

Dreamfolks Services hits new low, tanks 33% thus far in July; here's why
Updated On : 11 Jul 2025 | 11:15 AM IST

RPP Infra Projects shares hit upper circuit on ₹365.85 crore order win

RPP Infra Projects shares rose 5 per cent after it won an order worth ₹365.85 crore under the Jal Jeevan Mission

RPP Infra Projects shares hit upper circuit on ₹365.85 crore order win
Updated On : 11 Jul 2025 | 11:13 AM IST

Tata Elxsi share price tanks 8% on weak Q1 results; key details here

Tata Elxsi share price fell after reporting a weak set of results in the first quarter of financial year 2026 (Q1FY26).

Tata Elxsi share price tanks 8% on weak Q1 results; key details here
Updated On : 11 Jul 2025 | 10:57 AM IST

Zee Ent slips 7% as 40% shareholders vote against promoter warrants

Zee Entertainment share price slipped 6.7 per cent in trade, logging an intraday low at ₹133.05 per share; Details here

Zee Ent slips 7% as 40% shareholders vote against promoter warrants
Updated On : 11 Jul 2025 | 10:57 AM IST

IT shares under pressure on mixed TCS Q1 numbers; Nifty IT index down 2%

TCS, Infosys, Wipro, LTIMindtree, Tech Mahindra, HCL Technologies and Persistent Systems are down in the range of 1% to 2%.

IT shares under pressure on mixed TCS Q1 numbers; Nifty IT index down 2%
Updated On : 11 Jul 2025 | 10:54 AM IST

Anand Rathi Wealth gains 6% in trade after posting 28% rise in PAT in Q1

Anand Rathi Wealth share price gained 6 per cent on BSE, logging an intraday high at ₹2,250 per share after posting healthy Q1 numbers

Anand Rathi Wealth gains 6% in trade after posting 28% rise in PAT in Q1
Updated On : 11 Jul 2025 | 10:53 AM IST

Sebi's ban on Jane Street hits options volumes, rebound expected soon

Since the order, index options premium turnover on the NSE and BSE exchanges declined on a week-on-week basis in four of five sessions

Sebi's ban on Jane Street hits options volumes, rebound expected soon
Updated On : 11 Jul 2025 | 10:53 AM IST

JP Morgan backs Vedanta after Viceroy report, says "not getting distracted"

Analysts at JP Morgan believe Vedanta is cheap within the Asian and emerging market (EM) metals and mining space

JP Morgan backs Vedanta after Viceroy report, says "not getting distracted"
Updated On : 11 Jul 2025 | 10:24 AM IST

Glenmark Pharma soars 10%, hits 52-week high on cancer drug licensing deal

At 09:30 AM, Glenmark Pharma shares were trading at ₹2,094.40, up by 10 per cent on the National Stock Exchange.

Glenmark Pharma soars 10%, hits 52-week high on cancer drug licensing deal
Updated On : 11 Jul 2025 | 10:23 AM IST

Meta Infotech shares list at 40% premium on BSE SME, beat IPO GMP estimate

Meta Infotech shares listed at ₹225 per share, reflecting a premium of ₹64 or 39.75 per cent over the IPO issue price of ₹161

Meta Infotech shares list at 40% premium on BSE SME, beat IPO GMP estimate
Updated On : 11 Jul 2025 | 10:13 AM IST

HCL Tech Q1 preview: What to expect amid tariff jitters, seasonal weakness

HCL Technologies is expected to post a 3.76 per cent decline in net profit for the first quarter, sequentially

HCL Tech Q1 preview: What to expect amid tariff jitters, seasonal weakness
Updated On : 11 Jul 2025 | 10:08 AM IST

TCS stock breaks near-term support post Q1 show, can dip another 5%; charts

TCS share price slipped below the trend line support on the daily scale post Q1 results; the stock can potentially drop another 5 per cent, suggest technical charts.

TCS stock breaks near-term support post Q1 show, can dip another 5%; charts
Updated On : 11 Jul 2025 | 9:49 AM IST

Rupee snaps three-day gains on Tariff jitters; opens lower at 85.82/$

Indian Rupee today: The domestic currency opened 17 paise lower at 85.82 against the dollar on Friday

Rupee snaps three-day gains on Tariff jitters; opens lower at 85.82/$
Updated On : 11 Jul 2025 | 9:27 AM IST

India widens global investor access to $639 bn corporate credit market

The financial regulator for the special economic zone known as GIFT City has allowed global banks including HSBC Holdings Plc and Standard Chartered Plc to offer total return swaps for corporate bonds

India widens global investor access to $639 bn corporate credit market
Updated On : 11 Jul 2025 | 9:20 AM IST

Jane Street fallout hits NSE's pre-IPO valuation, sparks market concerns

The drop in NSE's unlisted shares follows a stunning surge since late October, fueled by hopes for a listing of the world's biggest equity-derivatives bourse

Jane Street fallout hits NSE's pre-IPO valuation, sparks market concerns
Updated On : 11 Jul 2025 | 9:17 AM IST

Sebi probe puts Jane Street's India trading strategy under spotlight

The regulator says that the high-frequency trading giant has made $4.3 billion from India in a little over two years, and so far its officers have only investigated trades in one index

Sebi probe puts Jane Street's India trading strategy under spotlight
Updated On : 11 Jul 2025 | 8:59 AM IST

Nuvama initiates 'Buy' on Hyundai India, sets ₹2,600 target on growth push

With $2.9 billion in average annual research and development (R&D) spend (2.5 per cent of revenue), the parent firm enables Hyundai India to fast-track innovation and expand exports.

Nuvama initiates 'Buy' on Hyundai India, sets ₹2,600 target on growth push
Updated On : 11 Jul 2025 | 8:42 AM IST